Financial Daily from THE HINDU group of publications
Monday, Apr 03, 2006
Financial Daily from THE HINDU group of publications Monday, Apr 03, 2006 |
|
|
|
|
|
|
|
Opinion
-
Letters Drug research
This is with reference to, "Drug cos on the path of innovation," (Business Line, April 2). This is a welcome change. And the call of Ms Kiran Mazumdar Shaw, the Biocon Chief that clinical research and innovation should converge with medical students looking at research and not just the practice, is timely. The decision of the Health Ministry to make comprehensive revisions of its guidelines on conducting clinical trials may give a boost to the clinical research industry. At the same time, the Government could also consider bringing required changes in the syllabus of medical education or introducing relevant post-graduate courses. India could emerge as a world leader in clinical research. A. Jacob Sahayam Thiruvananthapuram
Letters to the editor and contributions can be sent by e-mail to: bleditor@thehindu.co.in
More Stories on : Letters | Pharmaceuticals | Research & Development
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2006, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|